|
Post by Forever Sunshine on Apr 28, 2013 22:57:53 GMT -5
Should a life-saving drug that can be profitably sold for far less cost more than $100,000 per year?
A group of more than 120 cancer researchers and physicians took the unusual step this week of publishing a research paper taking aim at pharmaceutical prices they see as exorbitant and unjustifiable.
Drug companies are profiteering, the doctors say, by charging whatever the market will bear for medications that patients literally can't live without.
The paper, published online in the American Society of Hematology's medical journal Blood, analyzes and criticizes the cost of drugs used to treat chronic myeloid leukemia (CML), a rare type of cancer that responds very well to drug therapy. The 10-year survival rate for CML patients now tops 80% for those who receive targeted drugs -- but the annual price tag for the treatment is usually in the six-figure range.
Those prices bear little relation to what the drugs actually cost to develop and produce, the doctors say. As an example, they zero in on the case of imatinib, a drug sold by Novartis (NVS) as Gleevec (in the U.S.) or Glivec (in most international markets).
money.cnn.com/2013/04/25/news/economy/cancer-drug-cost/index.html?source=cnn_bin
|
|
|
Post by mox on Apr 29, 2013 15:40:01 GMT -5
A bit off subject, but I saw the other day that they have come up with a combo of drugs that in trials has cured Hepatitis C 100%. WOW! In six months time, no trace of it was found in some patients.
|
|
|
Post by Deleted on Apr 29, 2013 15:57:11 GMT -5
Do Doctors blast their OWN profession for what they earn? I dont' see any doctors in the verge of starvation or working at "cost".
|
|